Menu
respiratory

Acinetobacter baumannii Ventilator-Associated Pneumonia (VAP)

ICD-10 Code
J15.6

Clinical Criteria for Acinetobacter baumannii Ventilator-Associated Pneumonia (VAP).

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient is a mechanically ventilated individual presenting with new or progressive pulmonary infiltrates on chest imaging, accompanied by clinical signs of infection including fever, leukocytosis, and purulent tracheal secretions. Onset of symptoms occurred >48 hours post-intubation. Current clinical status indicates worsening oxygenation requirements, increased ventilator settings, and hemodynamic instability consistent with VAP.

Clinical Examination Findings

Physical examination reveals tachypnea, tachycardia, and diminished breath sounds with coarse crackles or rhonchi upon auscultation. Tracheal aspirate is thick and purulent. Patient exhibits increased work of breathing, accessory muscle use, and hypoxemia requiring escalation of FiO2. Hemodynamic assessment shows signs of systemic inflammatory response syndrome (SIRS).

Treatment Protocol

Initiate empiric antibiotic therapy targeting multidrug-resistant Acinetobacter baumannii, typically involving high-dose carbapenems (if susceptible) or colistin/polymyxin B in combination with tigecycline or sulbactam-based regimens. Optimize ventilator bundle protocols, including head-of-bed elevation (30-45 degrees), daily sedation vacations, and subglottic secretion drainage. Monitor renal function and adjust dosages accordingly.

Detailed clinical guide coming soon.